ID: ALA4209389

Max Phase: Preclinical

Molecular Formula: C21H15N5O2

Molecular Weight: 369.38

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cc1cccc(NC(=O)c2cc(C(=O)c3cncnc3)cc3cccnc23)n1

Standard InChI:  InChI=1S/C21H15N5O2/c1-13-4-2-6-18(25-13)26-21(28)17-9-15(8-14-5-3-7-24-19(14)17)20(27)16-10-22-12-23-11-16/h2-12H,1H3,(H,25,26,28)

Standard InChI Key:  MDNZTYQRDWFDBJ-UHFFFAOYSA-N

Associated Targets(non-human)

Metabotropic glutamate receptor 5 4372 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 369.38Molecular Weight (Monoisotopic): 369.1226AlogP: 3.21#Rotatable Bonds: 4
Polar Surface Area: 97.73Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 13.62CX Basic pKa: 3.47CX LogP: 2.27CX LogD: 2.27
Aromatic Rings: 4Heavy Atoms: 28QED Weighted: 0.55Np Likeness Score: -1.35

References

1. Felts AS, Rodriguez AL, Morrison RD, Blobaum AL, Byers FW, Daniels JS, Niswender CM, Conn PJ, Lindsley CW, Emmitte KA..  (2018)  Discovery of 6-(pyrimidin-5-ylmethyl)quinoline-8-carboxamide negative allosteric modulators of metabotropic glutamate receptor subtype 5.,  28  (10): [PMID:29705142] [10.1016/j.bmcl.2018.04.053]

Source